passages.id: 508
passages.type: sentence
passages.text: Rates of responses in patients adequately dosed ( i.e. , with significant hematotoxicity ) with amonafide ranged from 35 to 50 % .
entities.id: 509
entities.type: intervention
entities.text: amonafide
entities.id: 510
entities.type: outcome
entities.text: Rates of responses
entities.id: 511
entities.type: outcome
entities.text: hematotoxicity